Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term …

S Crippa, C Bassi, R Salvia, G Malleo, G Marchegiani… - Gut, 2017 - gut.bmj.com
Objective To evaluate mid-term outcomes and predictors of survival in non-operated patients
with pancreatic intraductal papillary mucinous neoplasms (IPMNs) with worrisome features …

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term …

S Crippa, C Bassi, R Salvia, G Malleo, G Marchegiani… - GUT, 2017 - research.unipd.it
Objective To evaluate mid-term outcomes and predictors of survival in non-operated patients
with pancreatic intraductal papillary mucinous neoplasms (IPMNs) with worrisome features …

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term …

S Crippa, C Bassi, R Salvia, G Malleo, G Marchegiani… - GUT, 2017 - iris.unisr.it
Objective To evaluate mid-term outcomes and predictors of survival in non-operated patients
with pancreatic intraductal papillary mucinous neoplasms (IPMNs) with worrisome features …

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term …

S Crippa, C Bassi, R Salvia, G Malleo, G Marchegiani… - Gut, 2016 - europepmc.org
Objective To evaluate mid-term outcomes and predictors of survival in non-operated patients
with pancreatic intraductal papillary mucinous neoplasms (IPMNs) with worrisome features …

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term …

S Crippa, C Bassi, R Salvia, G Malleo… - Gut, 2017 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate mid-term outcomes and predictors of survival in non-operated patients
with pancreatic intraductal papillary mucinous neoplasms (IPMNs) with worrisome features …

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: A mid-term …

S Crippa, C Bassi, R Salvia, G Malleo… - Gut, 2017 - mayoclinic.pure.elsevier.com
Objective To evaluate mid-term outcomes and predictors of survival in non-operated patients
with pancreatic intraductal papillary mucinous neoplasms (IPMNs) with worrisome features …

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term …

S Crippa, C Bassi, R Salvia, G Malleo, G Marchegiani… - Gut, 2016 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objective</jats: title>< jats: p> To evaluate mid-term outcomes
and predictors of survival in non-operated patients with pancreatic intraductal papillary …

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: A mid-term …

S Crippa, C Bassi, R Salvia, G Malleo… - Gut, 2017 - mayoclinic.elsevierpure.com
Objective To evaluate mid-term outcomes and predictors of survival in non-operated patients
with pancreatic intraductal papillary mucinous neoplasms (IPMNs) with worrisome features …

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term …

S Crippa, C Bassi, R Salvia, G Malleo, G Marchegiani… - Gut, 2017 - search.proquest.com
Objective To evaluate mid-term outcomes and predictors of survival in non-operated patients
with pancreatic intraductal papillary mucinous neoplasms (IPMNs) with worrisome features …

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term …

S Crippa, C Bassi, R Salvia, G Malleo, G Marchegiani… - GUT, 2017 - iris.univr.it
Objective To evaluate mid-term outcomes and predictors of survival in non-operated patients
with pancreatic intraductal papillary mucinous neoplasms (IPMNs) with worrisome features …